Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pajkrt, D.
Right arrow Articles by J.H. van Deventer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pajkrt, D.
Right arrow Articles by J.H. van Deventer, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia

D Pajkrt, T van der Poll, M Levi, DL Cutler, MB Affrime, A van den Ende, JW ten Cate and SJ van Deventer

Laboratory of Experimental Internal Medicine and Center for Hemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center, University of Amsterdam, The Netherlands.

Interleukin-10 (IL-10) has been found to inhibit lipopolysaccharide (LPS)-induced tissue factor expression by monocytes in vitro. To determine the effects of IL-10 on LPS-induced activation of the hemostatic mechanisms in vivo, we performed a placebo-controlled, cross- over study of human endotoxemia. Two groups of eight volunteers were challenged with LPS (4 ng/kg) on two occasions: once in conjunction with placebo, and once with recombinant human IL-10 (rhIL-10; 25 microg/kg). In group 1, placebo or rhIL-10 was given 2 minutes before LPS challenge, group 2 received placebo or rhIL-10 1 hour after LPS administration. Pretreatment with rhIL-10 reduced both LPS-induced activation of the fibrinolytic system (plasma concentrations of tissue type plasminogen activator, plasmin-alpha2-antiplasmin complexes, and D- dimer), and inhibition of fibrinolysis (plasma levels of plasminogen activator inhibitor 1), whereas posttreatment only inhibited the latter response. Both IL-10 pre- and posttreatment attenuated activation of the coagulation system (plasma levels of prothrombin fragment F1 + 2 and thrombin-antithrombin complexes). These results indicate that rhIL- 10, besides its well-described inhibitory effects on cytokine release, potently modulates the fibrinolytic system and inhibits the coagulant responses during endotoxemia.

Volume 89, Issue 8, pp. 2701-2705, 04/15/1997
Copyright © 1997 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
N. Tamassia, F. Calzetti, N. Menestrina, M. Rossato, F. Bazzoni, L. Gottin, and M. A. Cassatella
Circulating neutrophils of septic patients constitutively express IL-10R1 and are promptly responsive to IL-10
Int. Immunol., April 1, 2008; 20(4): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
M. Bahador and A. S. Cross
Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects
Innate Immunity, October 1, 2007; 13(5): 251 - 279.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Garantziotis, D. M. Brass, J. Savov, J. W. Hollingsworth, E. McElvania-TeKippe, K. Berman, J. K. L. Walker, and D. A. Schwartz
Leukocyte-Derived IL-10 Reduces Subepithelial Fibrosis Associated with Chronically Inhaled Endotoxin
Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 662 - 667.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp
Infections and endothelial cells
Cardiovasc Res, October 15, 2003; 60(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. Asadullah, W. Sterry, and H. D. Volk
Interleukin-10 Therapy--Review of a New Approach
Pharmacol. Rev., June 1, 2003; 55(2): 241 - 269.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
T. van der Poll
Coagulation and inflammation
Innate Immunity, August 1, 2001; 7(4): 301 - 304.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
A. A. M. Dias, A. R. Goodman, J. L. Dos Santos, R. N. Gomes, A. Altmeyer, P. T. Bozza, M. de Fatima Horta, J. Vilcek, and L. F. L. Reis
TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis
J. Leukoc. Biol., June 1, 2001; 69(6): 928 - 936.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. S. Gerber and D. M. Mosser
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fc{{gamma}} Receptors
J. Immunol., June 1, 2001; 166(11): 6861 - 6868.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
X. Peng, D. M. Mosser, M. W. Adler, T. J. Rogers, J. J. Meissler Jr, and T. K. Eisenstein
Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages
J. Leukoc. Biol., November 1, 2000; 68(5): 723 - 728.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
F. N. Lauw, D. Pajkrt, C. E. Hack, M. Kurimoto, S. J. H. van Deventer, and T. van der Poll
Proinflammatory Effects of IL-10 During Human Endotoxemia
J. Immunol., September 1, 2000; 165(5): 2783 - 2789.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. F. Franco, E. de Jonge, P. E. P. Dekkers, J. J. Timmerman, C. A. Spek, S. J. H. van Deventer, P. van Deursen, L. van Kerkhoff, B. van Gemen, H. ten Cate, et al.
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Blood, July 15, 2000; 96(2): 554 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
X. R. HUANG, A. R. KITCHING, P. G. TIPPING, and S. R. HOLDSWORTH
Interleukin-10 Inhibits Macrophage-Induced Glomerular Injury
J. Am. Soc. Nephrol., February 1, 2000; 11(2): 262 - 269.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y. Ding, L. Qin, S. V. Kotenko, S. Pestka, and J. S. Bromberg
A Single Amino Acid Determines the Immunostimulatory Activity of Interleukin 10
J. Exp. Med., January 17, 2000; 191(2): 213 - 224.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. J. Elenkov, E. Webster, D. A. Papanicolaou, T. A. Fleisher, G. P. Chrousos, and R. L. Wilder
Histamine Potently Suppresses Human IL-12 and Stimulates IL-10 Production via H2 Receptors
J. Immunol., September 1, 1998; 161(5): 2586 - 2593.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. J. Downing, R. M. Strieter, A. M. Kadell, C. A. Wilke, J. C. Austin, B. D. Hare, M. D. Burdick, L. J. Greenfield, and T. W. Wakefield
IL-10 Regulates Thrombus-Induced Vein Wall Inflammation and Thrombosis
J. Immunol., August 1, 1998; 161(3): 1471 - 1476.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Okada, T. Fujita, K. Minamoto, H. Liao, Y. Naka, and D. J. Pinsky
Potentiation of Endogenous Fibrinolysis and Rescue from Lung Ischemia/Reperfusion Injury in Interleukin (IL)-10-reconstituted IL-10 Null Mice
J. Biol. Chem., July 7, 2000; 275(28): 21468 - 21476.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020